Opendata, web and dolomites
H2020 projects about "parkinson"
The page lists 168 projects related to the topic "parkinson".
| # | |||
|---|---|---|---|
| 1 | FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone | 2015 |
| 2 | PROPAG-AGEING | The continuum between healthy ageing and idiopathic Parkinson Disease within a propagation perspective of inflammation and damage: the search for new diagnostic, prognostic and therapeutic targets | 2015 |
| 3 | REMOTIVATE | Reward revisited: Towards a comprehensive understanding of motivational influences on human cognition | 2015 |
| 4 | PD_manager | mhealth platform for Parkinson’s disease management | 2015 |
| 5 | MAMEM | Multimedia Authoring and Management using your Eyes and Mind | 2015 |
| 6 | PROPHETIC | PROPHETIC:An innovating Personal Healthcare Service for a holistic remote management and treatment of Parkinson patients. | 2015 |
| 7 | SynChI | Striatal cholinergic cell assemblies in movement disorders | 2015 |
| 8 | BAS-SBBT | Bacterial Amyloid Secretion: Structural Biology and Biotechnology. | 2015 |
| 9 | MitSyn | Alpha-synuclein and mitochondrial dysfunction: key links between Gaucher’s disease and Parkinson’s? | 2015 |
| 10 | THALAMODEL | Multimodal, high-resolution modeling of the thalamus for neuroimaging studies: application to dyslexia | 2015 |
| 11 | CircaDopamine | The Role of Dopamine in the Regulation of Sleep and Circadian Rhythms | 2015 |
| 12 | STOP-Beta | Selectively Targeting Oscillations in Parkinson's disease: Causal effects of the beta-rhythm on motor control | 2015 |
| 13 | QTMODEM | Quantitative Motor Control for Decision Making | 2016 |
| 14 | MediVAC | Bio-sustainable production of natural medicines from Vitex | 2015 |
| 15 | HEALTHYSYNAPSES | Molecular mechanisms underlying synaptic maintenance and rejuvenation | 2016 |
| 16 | MELANOPARK | Investigating the LRRK2-melanin connection through phosphoproteomics of isogenic melanoma cells | 2015 |
| 17 | NeuroRhomboid | Discovering the signalling pathways and physiology of active rhomboid proteases in the brain | 2015 |
| 18 | RECOLOR | Regulation and consequences of LRRK2 phosphorylation,a path to Parkinson’s disease therapy and diagnostics | 2015 |
| 19 | OLIGOBINPRO | Non-canonical nucleoside incorporation into synthetic RNA-oligonucleotides: investigations towards the discovery of selective RNA-binding proteins | 2015 |
| 20 | eADAM | Ultra-small electrochemical aptasensors for specific dopamine real-time monitoring | 2016 |
| 21 | CONTESSA | COuNt data TimE SerieS Analysis: significance tests and sequencing data application | 2015 |
| 22 | ROSNPD | Selective vulnerability of neuronal degeneration in Parkinson’s disease: the load of routine behaviour | 2016 |
| 23 | NEUMARQ | Neurodegenerative disease biomarkers based on high quality wireless EEG. | 2015 |
| 24 | PARK-IT | Unobtrusive, continuous and quantitative assessment of Parkinson’s disease: hard evidence for optimal disease management with information technologies | 2015 |
| 25 | NeuroInCellNMR | In-cell NMR monitoring of alpha-Synuclein aggregation in neuronal cells | 2015 |
| 26 | MEMEMTUM | Neurological evaluation with simple tools to track evolution and perform early detection of neurodegenerative issues | 2015 |
| 27 | DBSModel | Multiscale Modelling of the Neuromuscular System for Closed Loop Deep Brain Stimulation | 2015 |
| 28 | METALS | Formation and Characterization of Protein Post-Translational Modifications and Assessment of Cellular Responses by Application of Metals in Biological Systems | 2015 |
| 29 | BeadDiagnosis | Prognosis and Diagnosis of Protein Misfolding Diseases by Seeded Aggregation in Microspheres | 2015 |
| 30 | PROGSY | Prosaposin and GPR37 in synucleinopathies | 2015 |
| 31 | UPR NEURO | The Unfolded Protein Response in Neurodegeneration | 2015 |
| 32 | TASPPI | Targeted small-molecule Stabilisation of Protein-Protein Interactions | 2016 |
| 33 | BrainMatTrain | Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach | 2016 |
| 34 | Oligomers | Characterising protein oligomers and their role in neurodegenerative disease in humans | 2015 |
| 35 | Biomarkers for PD | Validation of diagnostic and prognostic biomarkers for Parkinson disease | 2015 |
| 36 | RobustSynapses | Maintaining synaptic function for a healthy brain: Membrane trafficking and autophagy in neurodegeneration | 2016 |
| 37 | PRION2020 | Function and malfunction of the prion protein | 2015 |
| 38 | ANGEO2 | For cognitively-impaired or visually-impaired persons suffering from spatial disorientation, a smartphone-based navigation aid that is both reliable and safe for urban pedestrian mobility. | 2015 |
| 39 | MAGNEURON | Hijacking cell signalling pathways with magnetic nanoactuators for remote-controlled stemcell therapies of neurodegenerative disorders | 2016 |
| 40 | microCrysFact | Microfluidic Crystal Factories (μ-CrysFact): a breakthrough approach for crystal engineering | 2016 |
| 41 | i-PROGNOSIS | Intelligent Parkinson eaRly detectiOn Guiding NOvel Supportive InterventionS | 2016 |
| 42 | SysMedPD | Systems Medicine of Mitochondrial Parkinson’s Disease | 2015 |
| 43 | ICT4Life | ICT services for Life Improvement For the Elderly | 2016 |
| 44 | CENTRE-PD | TWINNING for a Comprehensive Clinical Centre for the Diagnosis and Treatment of Parkinson's Disease | 2016 |
| 45 | MPA-ND | Membrane protein aggregation and its links with neurodegenerative diseases | 2016 |
| 46 | NEUROTUNN | Mechanisms of α-synuclein spreading, implications for synucleinopathies | 2016 |
| 47 | IFNBetaMito | Role of IFN-β in mitochondrial homeostasis and impact on Parkinson Disease | 2016 |
| 48 | AVISSO | Audiovisual Speech Segmentation and Oscillations | 2016 |
| 49 | VIBRANT-BIO | High-throughput vibrational fingerprinting by nanoplasmonics for disease biology | 2017 |
| 50 | MESO_BRAIN | Custom architecturally defined 3D stem cell derived functional human neural networks for transformative progress in neuroscience and medicine | 2016 |
| 51 | Neurotoxic | An Ultra-sensitive Assay to Measure Oligomer Induced Toxicity in Human Cerebrospinal Fluid | 2016 |
| 52 | Neuro Care System | Adaptive Neuro Care System | 2016 |
| 53 | Tech4Freedom 2.0 | Assistive Devices for the Visually Impaired and other Disabilities | 2016 |
| 54 | LYSOSOMICS | Functional Genomics of the Lysosome | 2016 |
| 55 | BEND | Bendable Bioplatform for Electrically stimulated Neuronal Differentiation | 2016 |
| 56 | SYNDEGEN | Synaptic dysfunction in Neurodegenerative Diseases | 2017 |
| 57 | Training4CRM | European Training Network for Cell-based Regenerative Medicine | 2016 |
| 58 | REMIX | Regulation of mitochondrial expression | 2016 |
| 59 | CONNEXIO | Physiologically relevant microfluidic neuro-engineering | 2016 |
| 60 | MADIA | Magnetic DIagnostic Assay for neurodegenerative diseases | 2017 |
| 61 | toxiclipasyn | Understanding the balance between functional and deleterious interactions of alpha-synuclein with lipid bilayers | 2017 |
| 62 | OSCANN | Diagnosing platform for neurological and mental disorders based on the analysis of ocular and oculocephalic movements. | 2017 |
| 63 | TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery | 2017 |
| 64 | FORMAT | FORMAT: a novel medium FOr Revolutionizing stem cell MAnufacturing Technologies | 2017 |
| 65 | NEW-AGE | A next-generation platform for catalysing pre-clinical development of drugs against Alzheimer’s and other degenerative diseases of old-age | 2017 |
| 66 | NeuronAgeScreen | A Drug Discovery and Target Identification Screening Platform for Age-Associated Neurodegenerative Disorders | 2017 |
| 67 | MINERVA | MIcrobiota-Gut-BraiN EngineeRed platform to eVAluate intestinal microflora impact on brain functionality | 2017 |
| 68 | FreezeAlz | Theoretical prediction of spectral biomarkers for Alzheimer's disease enabled by highly efficient and adaptable mutli-level response methods | 2017 |
| 69 | PARK-IT 2.0 | Unobtrusive, Continuous and Quantitative Assessment of Parkinson’s disease: Hard Evidence for Optimal Disease Management with Information Technologies | 2017 |
| 70 | CAB | Cognition, ageing, and bilingualism: Investigating age-related changes in bilingual language switching and use. | 2017 |
| 71 | NeuroTRACK | Tracking and predicting neurodegeneration spreading across the brain connectome | 2017 |
| 72 | UbiArchitect | Understanding the complexity and architecture in protein ubiquitination | 2017 |
| 73 | funcSOFI-PD | Quantitative super-resolution optical fluctuation and phase microscopy for structural and functional imaging of Parkinson's disease | 2017 |
| 74 | Motivageing | Motivation–cognition interaction in healthy ageing and Parkinson’s disease | 2018 |
| 75 | MITOQUAD | Unveiling the mitochondrial role of DNA2, a human helicase-nuclease causing mtDNA deletion associated syndrome. | 2018 |
| 76 | IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060 | 2017 |
| 77 | CORFEDITING | Gene Editing as Therapeutic Strategy for C9ORF72 Linked ALS/FTD | 2017 |
| 78 | BETACONTROL | Control of amyloid formation via beta-hairpin molecular recognition features | 2017 |
| 79 | MOWOOT | Integral Intestinal Transit Management System for chronic constipation | 2017 |
| 80 | PRIMATE-TE-IMPACT | Mapping the retrotransposon-mediated layer of neuronal gene regulation in the human genome | 2017 |
| 81 | TAPAS | Training Network on Automatic Processing of PAthological Speech | 2017 |
| 82 | FRONTHAL | Specificity of cortico-thalamic interactions and its role in frontal cortical functions | 2017 |
| 83 | PD UpReg | Gene knock-up via 3’UTR targeting to treat Parkinson’s disease | 2017 |
| 84 | STARDUST | in vivo optogeneticS, elecTrophysiology and phArmacology with an ultRasonically-powered DUST for Parkinson's Disease | 2017 |
| 85 | Dam2Age | DNA Damage and Repair and its Impact on Healthy Ageing | 2017 |
| 86 | EXTEND | Bidirectional Hyper-Connected Neural System | 2018 |
| 87 | UPRECON | Ultrafast photonics for the detection and recognition of toxic spine-structures of amyloid aggregates linked to neurodegenerative disease | 2018 |
| 88 | Tremipen | The first simple monitoring device for Parkinson and other Tremor diseases | 2017 |
| 89 | NeuroPsyCAD | Artificial Intelligence for early and accurate neuropsychiatric diagnosis | 2017 |
| 90 | Brain2Bee | How dopamine affects social and motor ability - from the human brain to the honey bee | 2018 |
| 91 | BTech | Novel human neurodegenerative disease specific 3D cell-models with applications in drug development and toxicity testing | 2018 |
| 92 | CROSS-NEUROD | Transferring autonomous and non autonomous cell degeneration 3D models between EU and USA for development of effective therapies for neurodegenerative diseases (ND) | 2018 |
| 93 | GOKNOT | Modelling the formation of a gordian knot in Human Ubiquitin Hydrolase | 2018 |
| 94 | Alpha-Synuclein | Blocking the prion-like disease propagation in Parkinson’s disease and related disorders – model development and identification of cell-autonomous and cell non-autonomous factors. | 2019 |
| 95 | BOLD-NMR | Biomolecular structures elucidated by cOLD magic angle spinning NMR with dynamic nuclear polarization | 2018 |
| 96 | BRAIN CAMO | Camouflaging electronics in the brain with immobilized liquid coatings | 2018 |
| 97 | BrainBehaviourModel | Understanding decision making by linking brain and behaviour | 2018 |
| 98 | TrueBrainConnect | Advancing the non-invasive assessment of brain communication in neurological disease | 2019 |
| 99 | MultiSpecAMYLOID | A MULTI-SPECTROSCOPIC APPROACH TO PROBE AMYLOID AGGREGATION AT BIOLOGICAL SURFACES | 2018 |
| 100 | NOJUNKDNA | A strategy to investigate cell type-specific effects of non-coding regulatory elements to be applied in neurodegeneration research | 2018 |
| 101 | gaitDCODE | Decoding impairments of gait and balance from local field potentials in patients with Parkinson's disease. | 2018 |
| 102 | OSCBAGDIS | Oscillations in Basal Ganglia Disorders | 2018 |
| 103 | TOLKEDA | Modulating brain structural plasticity versus neurodegeneration via a novel mechanism involving neurotrophins and dopamine, Tolls and Kek truncated-Trk-like receptors in Drosophila. | 2018 |
| 104 | NeuroLSD | Neuro-metabolic, structural and functional hallmarks of Lysosomal Storage Diseases | 2018 |
| 105 | STRIAVISE | How the striatum contributes to visual-selection | 2018 |
| 106 | TUNING-BRAKES | Fine-tuning the brain’s brakes – modulating inhibitory control with transcranial alternating current stimulation | 2019 |
| 107 | Gut_Fights_PD | Investigating protective mechanisms of gut bacteria in C. elegans models of Parkinson’s disease | 2019 |
| 108 | CORLID | Cortical markers of L-DOPA-induced dyskinesias | 2019 |
| 109 | MAPSYNE | Miniaturized automated patch-clamp system combined with high-density microelectrode arrays for multi-scale functional mapping of neuronal networks | 2018 |
| 110 | Gut_Fights_PD | Investigating protective mechanisms of gut bacteria in C. elegans models of Parkinson’s disease | 2019 |
| 111 | Neurocloud | CLOUD-BASED MULTIMODAL NEUROIMAGING PLATFORM | 2018 |
| 112 | NS System | A real-time and continuous brain monitoring system to record and track brain activity and extract biomarkers for neurological conditions | 2018 |
| 113 | KHON2bTREAT | Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market | 2018 |
| 114 | UpSurgeOn Academy | UpSurgeOn Academy: A multilevel educational platform for neurosurgical training. | 2018 |
| 115 | NeuroProtect | Novel Drug Therapy with Potential to Cure Neuro-Degenerative Diseases | 2018 |
| 116 | PET-AlphaSy | PET Imaging of Alpha-Synuclein Fibril Formation | 2018 |
| 117 | CoPs | Continuous hazardous water Pollutants sensing in the environment | 2018 |
| 118 | SAFELDER | POINT ACTIVE AGEING ASSISTIVE SERVICE – A MULTI-SENSOR SINGLE DEVICE FOR SMART MONITORING OF THE ELDERLY PEOPLE | 2018 |
| 119 | TREAT-PD | Patient-specific treatment for Parkinson's disease using reprogrammed skin cells | 2018 |
| 120 | CONNECT | Connecting neural networks: Nervous-system-on-Chip Technology | 2019 |
| 121 | IRL790 | NOVEL THERAPEUTIC FOR THE TREATMENT OF PARKINSONS DISEASE | 2018 |
| 122 | gSKIN BodyTemp | Integration of Heat flux sensor in (wrist) wearable devices for accurately and non-invasively continuous monitoring of core body temperature (CBT) for the early detection of health-related disorders | 2018 |
| 123 | GONDOLA | Automated Mechanical Peripheral Stimulation for motor rehabilitation in people living with Parkinson’s Disease (PD) | 2018 |
| 124 | GyroGlove | Development and Commercialisation of an Intelligent Wearable Platforms to Stabilise Hand Tremors in Parkinson’s Disease and Essential Tremor | 2018 |
| 125 | PD_Pal | Palliative care in Parkinson’s disease | 2019 |
| 126 | FutureTrophicFactors | Elucidating therapeutic effects and mode of action of future trophic factorsin ALS and Parkinson’s disease | 2019 |
| 127 | ReHaptix | Easy-to-use and highly accurate medical software for quantitative assessment of impairments in neurologically injured people. | 2019 |
| 128 | SWALLIS | SWALLIS - a disruptive wearable device that uses sound patterns to diagnose and monitor swallowing disorders | 2019 |
| 129 | SCAMPICITY | cAMP-dependend plasticity of striatal projection neurons in health and disease | 2019 |
| 130 | MicroSPARK | A Single-Molecule Technology for Resolving Chaperone Action in Neurodegenerative Diseases | 2019 |
| 131 | NMJ | Neuromuscular-Junction-on-a-Chip to study medication for Parkinson | 2019 |
| 132 | PD-MitoQUANT | PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease | 2019 |
| 133 | COLIBRI | Click chemistry Options for Live Immuno Brain Imaging | 2019 |
| 134 | PARNANT | Pathogenetic pathways in age-related neurodegenerations as novel therapeutic targets for Parkinson’s disease | 2019 |
| 135 | HYMNS | Hypothalamic Modulation of Neocortical States | 2020 |
| 136 | Prion Respiration | The Role of Complex I Assembly Factors during Prion Diseases: Insights into Mitochondrial Neurobiology | 2019 |
| 137 | PD-MIND | Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug | 2019 |
| 138 | THERAPE | Novel blood-brain barrier permeable CDNF-derived therapeutic peptides for the protection and regeneration of dopamine neurons | 2019 |
| 139 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 140 | NG2-cells | The role of NG2 cells in the neural network in health and disease | 2019 |
| 141 | BrainInformationFlow | Principles underlying information flow across the entire brain of the zebrafish | 2020 |
| 142 | MOBILISE-D | Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement | 2019 |
| 143 | STRELECOID | Stretchable mesh-electrodes interfacing human iPSC brain organoids | 2019 |
| 144 | Nocturne | The eye as a window to the brain, extending lifelong brain health | 2019 |
| 145 | HARPER | Home based Augmented Reality Platform for Efficient Rehabilitation of stroke patients | 2019 |
| 146 | AmInnovation | Disruptive Innovation to Treat Alzheimer’s and Parkinson’s diseases: new target, new patented drug, new therapeutic strategy. | 2019 |
| 147 | Nano_Brain | Improving drug delivery to the brain and glioblastoma treatment using temperature. | 2019 |
| 148 | TARGET SLEEP | Boosting motor learning through sleep and targeted memory reactivation in ageing and Parkinson’s disease | 2020 |
| 149 | MPT system | Innovative, cost-effective, ultra-compact MRI-guided therapy system for diagnosis and immediate treatment of Parkinson's Disease | 2019 |
| 150 | CRESCENT | CRESCENT: Adaptive hands-free controller for people with disabilities | 2019 |
| 151 | In-Cytes | IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS | 2019 |
| 152 | TeNDER | affecTive basEd iNtegrateD carE for betteR Quality of Life | 2019 |
| 153 | Path Feel | Insoles for Neuropathy and Balance Issues | 2019 |
| 154 | SA-VOIR | Assessing the feasibility of MT-011, a first-in-class drug to treat glaucoma and other neurodegenerative diseases via a breakthrough mechanism-of-action | 2019 |
| 155 | MindTrack | Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders | 2019 |
| 156 | DBScontrol | Implementation and preclinical testing of a closed-loop control system for deep brain stimulation | 2020 |
| 157 | NSC-Reconstruct | Novel Strategies for Cell-based Neural Reconstruction | 2020 |
| 158 | DIANA | Organ-on-a-chip Drug screenIng device to tArget braiN diseAse | 2020 |
| 159 | GONDOLA AMPS | An innovative solution to neurological walking and balance disabilities | 2020 |
| 160 | ExpoBiome | Deciphering the impact of exposures from the gut microbiome-derived molecular complex in human health and disease | 2020 |
| 161 | Proteomes-in-3D | Three-dimensional dynamic views of proteomes as a novel readout for physiological and pathological alterations | 2020 |
| 162 | FACEDIFF | Individual differences in facial expressivity: Social function, facial anatomy and evolutionary origins | 2020 |
| 163 | BMPARK | Development of BMP2 Neurotrophic Therapy for Parkinson’s Disease | 2020 |
| 164 | SUPD | Sizing Up PD: Cavity-enhanced Characterisation of Single Biomarkers in Human Biofluids | 2020 |
| 165 | LySyT | Understanding the role of lysosomes in the intercellular TNT-mediated spreading of α-synuclein and the impact of lysosomal dysfunction | 2020 |
| 166 | StartAct | Controlling forelimb actions through basal ganglia to brainstem signaling | 2021 |
| 167 | SM-SPAD | Single-molecule imaging with SPAD array detection | 2021 |
| 168 | HT4PD | The role of the serotonin 5-HT4 receptor in motor and non-motor symptoms of Parkinson’s disease | 2021 |